Dexmedetomidine for Prophylaxis Against PONV in Highly Susceptible Patients.

NCT05134363 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Postoperative Nausea and Vomiting
Head and Neck Surgeries

Interventions

DRUG: Dexmedetomidine Hydrochloride 0.5 mic/kg bolus
DRUG: Dexmedetomidine Hydrochloride 0.75 mic/kg bolus
DRUG: Placebo

Sponsor

Cairo University